Kai Dun Tang
Overview
Explore the profile of Kai Dun Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weeramange C, Tang K, Irwin D, Hartel G, Langton-Lockton J, Ladwa R, et al.
Carcinogenesis
. 2024 Jan;
45(3):140-148.
PMID: 38270218
Despite the rising incidence, currently, there are no early detection methods for HPV-driven HNC (HPV-HNC). Cervical cancer studies suggest that HPV DNA methylation changes can be used as a biomarker...
2.
Tang K, Amenabar J, Schussel J, Torres-Pereira C, Bonfim C, Dimitrova N, et al.
Odontology
. 2023 Jul;
112(1):299-308.
PMID: 37458838
The overarching goal of this study is to predict the risk of developing oral squamous cell carcinoma (OSCC) in Fanconi anemia (FA) patients. We have compared the microRNA (miRNA, miR)...
3.
Weeramange C, Tang K, Barrero R, Hartel G, Liu Z, Ladwa R, et al.
Cancer Med
. 2023 Jun;
12(14):15128-15140.
PMID: 37278132
Background: Despite the rising incidence, particularly of the human papillomavirus (HPV)-associated fraction of oropharyngeal cancer (OPC), there are no early detection methods for OPC. Considering the close association between saliva...
4.
Tang K, Weeramange C, Vider J, Hartel G, West N, McMillan N, et al.
Oral Oncol
. 2022 Oct;
135:106215.
PMID: 36274347
No abstract available.
5.
Weeramange C, Shu D, Tang K, Batra J, Ladwa R, Kenny L, et al.
Cancer
. 2022 Feb;
128(10):1937-1947.
PMID: 35176174
Background: Although the majority of human papillomavirus (HPV) infections are cleared by the immune system, a small percentage of them progress to develop HPV-driven cancers. Cervical cancer studies highlight that...
6.
Tang K, Wan Y, Zhang X, Bozyk N, Vasani S, Kenny L, et al.
Mol Diagn Ther
. 2021 Jun;
25(4):505-515.
PMID: 34080172
Background: Increasing evidence supports the notion that human papillomavirus (HPV) DNA integration onto the human genome can influence and alter the molecular cargo in the exosomes derived from head and...
7.
Wan Y, Zhang X, Tang K, Blick T, Kenny L, Thompson E, et al.
Mol Biol Rep
. 2021 May;
48(5):3979-3989.
PMID: 34021445
Oral cavity cancer (OCC) is the predominant subtype of head and neck cancer (HNC) and has up to 50% mortality. Genome-wide microRNA (miR) sequencing data indicates overexpression of miR-9-5p in...
8.
Lim Y, Tang K, Karpe A, Beale D, Totsika M, Kenny L, et al.
Head Neck
. 2021 Feb;
43(5):1521-1534.
PMID: 33527579
Background: Patients with oral cavity cancer (OCC) and oropharyngeal cancer (OPC) are often seen with locoregionally advanced disease requiring complex multimodality treatments. These treatments may have detrimental effects on the...
9.
Weeramange C, Tang K, Vasani S, Langton-Lockton J, Kenny L, Punyadeera C
Cells
. 2020 Jun;
9(6).
PMID: 32486347
Disruption of DNA methylation patterns is one of the hallmarks of cancer. Similar to other cancer types, human papillomavirus (HPV)-driven head and neck cancer (HNC) also reveals alterations in its...
10.
Tang K, Vasani S, Taheri T, Walsh L, Hughes B, Kenny L, et al.
Front Oncol
. 2020 Apr;
10:408.
PMID: 32296641
Oropharyngeal cancer (OPC) caused by human papillomavirus (HPV) is a rising global concern. Early lesions are small and are often located in difficult to access areas (such as the crypts...